However, the widespread publicity and popularity of GLP-1 drugs for weight loss management led to a surge in demand
3 However, the latest American Diabetes Association and Kidney Disease: Improving Global Outcomes guidelines now recommend glucagon-like peptide-1 (GLP-1) receptor agonists, with or without metformin, as initial pharmacotherapy for patients with type 2 diabetes who are at high risk for cardiovascular disease, heart failure, or CKD
You also may feel more tired than usual if youre having trouble eating or are not taking in the same amount of nutrients as before
Stabilize, then shop Once GLP-1 users see their weight stabilize, they are more likely to buy pricier clothing
Thats a brand claim, not an independently verified one, since no product-specific adverse-event data or finished-product safety study is published on the site